Intercept Pharmaceuticals Inc. (ICPT) announced Tuesday morning that it has priced an underwritten public offering of 1,200,000 shares of its common stock.
Intercept Pharmaceuticals has gapped open sharply lower this morning and is now down 12.05 at $283.86. The stock is trading near the middle of over a 3-week range.
For comments and feedback contact: editorial@rttnews.com
Business News